The number of medications available to treat diabetes continues to increase. Recently, there has been widespread interest in two classes of medications, the SGLT2 inhibitors and the GLP1 agonists. They have created quite the splash with improvements in cardiovascular outcomes in patients with type 2 diabetes. In this podcast...

Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell

This podcast from NEJM Resident 360 takes a deep dive into key topics with expert clinicians and educators. As we explore the details of pathophysiology and critique the evidence behind clinical practice, these conversations are intended to give you better understanding of the topic and greater confidence when treating your patients.

Share Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell

Sign up to save your podcasts

Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell

Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell

More shows like Curbside Consults

NEJM This Week

NEJM Interviews

JAMA Clinical Reviews

Clinical Conversations

Peds in a Pod: A Pediatric Board Review

The Curbsiders Internal Medicine Podcast

The Daily

Leadership Conversations

The Clinical Problem Solvers

NEJM AI Grand Rounds

Intention to Treat

Not Otherwise Specified

Drowning Creek

Knowledgeable Provider